-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, BTrFaPifZ/P5Tgt8QUFOKg/XYciYedB7clbpX7sGOjOaPPYSn/jQwKK3i/sxhuiq tsau5SLb65zqOAMG/gzcRw== 0001095449-04-000113.txt : 20040804 0001095449-04-000113.hdr.sgml : 20040804 20040804130948 ACCESSION NUMBER: 0001095449-04-000113 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20040804 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: CELLEGY PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000887247 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 820429727 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-45279 FILM NUMBER: 04950847 BUSINESS ADDRESS: STREET 1: 349 OYSTER POINT BLVD. STREET 2: SUITE 200 CITY: SO. SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 6506262200 MAIL ADDRESS: STREET 1: 349 OYSTER POINT BLVD. STREET 2: SUITE 200 CITY: SO. SAN FRANCISCO STATE: CA ZIP: 94080 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: FULLER & THALER ASSET MANAGEMENT /CA CENTRAL INDEX KEY: 0001082327 IRS NUMBER: 94317968 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 411 BOREL AVE STREET 2: STE 402 CITY: SAN MATEO STATE: CA ZIP: 94402 BUSINESS PHONE: 6505728334 MAIL ADDRESS: STREET 1: 411 BOREL, SUITE 402 CITY: SAN MATEO STATE: CA ZIP: 94402 SC 13G 1 ia13g.txt SCHEDULE 13G FOR JULY 31, 2004 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Amendment No. ____) Under the Securities Exchange Act of 1934 Cellegy Pharmaceuticals, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 15115L103 (CUSIP Number) July 31, 2004 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) For IA & IAR [ ] Rule 13d-1(c) For LP if any [ ] Rule 13d-1(d) *The remainder of this cover page shall be filled out or a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 15115L103 SCHEDULE 13G Page 2 of 5 1 Name of Reporting Person Fuller & Thaler Asset Management, Inc. IRS Identification No. of Above Person 94-3176968 2 Check the Appropriate Box if a Member of a Group (a) [ ] (b) [ ] 3 SEC USE ONLY 4 Citizenship or Place of Organization California 5 Sole Voting Power 902,300 NUMBER OF 6 Shared Voting Power SHARES BENEFICIALLY -0- OWNED BY EACH REPORTING 7 Sole Dispositive Power PERSON WITH 1,068,300 8 Shared Dispositive Power -0- 9 Aggregate Amount Beneficially Owned by each Reporting Person 1,068,300 10 Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares* [ ] 11 Percent of Class Represented by Amount in Row 9 5.3% 12 Type of Reporting Person* CO, IA CUSIP No. 15115L103 SCHEDULE 13G Page 3 of 5 Item 1(a). Name of Issuer. Cellegy Pharmaceuticals, Inc. Item 1(b). Address of Issuer's Principal Executive Offices. 349 Oyster Point Boulevard, Suite 200, South San Francisco, CA 94080 Item 2(a). Names of Persons Filing. Fuller & Thaler Asset Management, Inc. Item 2(b). Address of Principal Business Office or, if none, Residence. The business address of Fuller & Thaler Asset Management, Inc. is 411 Borel Avenue, Suite 402, San Mateo, CA 94402. Item 2(c). Citizenship. Fuller & Thaler Asset Management, Inc. is a California corporation. Item 2(d). Title of Class of Securities. Common Stock Item 2(e). CUSIP Number. 15115L103 Item 3. If this statement is filed pursuant to 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: (a) [ ] Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o). (b) [ ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). (c) [ ] Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c). (d) [ ] Investment company registered under section 8 of the Investment Company act of 1940 (15 U.S.C. 80a-8). (e) [X] An investment adviser in accordance with 240.13d- 1(b)(1)(ii)(E). CUSIP No. 15115L103 SCHEDULE 13G Page 4 of 5 (f) [ ] An employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F). (g) [ ] A parent holding company or control person in accordance with 240.13b-1(b)(1)(ii)(G). (h) [ ] A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813). (i) [ ] A church plan that is excluded form the definition of an investment company under section 3(c)(14) of the Investment Company act of 1940 (15 U.S.C. 80a-3). (j) [ ] Group, in accordance with 240.13d-1(b)(1)(ii)(J). Item 4. Ownership. Reference is made hereby made to Items 5-9 and 11 of page two (2) of this Schedule 13G, which Items are incorporated by reference herein. Item 5. Ownership of Five Percent or Less of a Class. Not applicable. Item 6. Ownership of More Than Five Percent on Behalf of Another Person. Fuller & Thaler Asset Management, Inc. is deemed to be the beneficial owner of the number of securities reflected in Item 5-9 and 11 of page two (2) of this Schedule 13G pursuant to separate arrangements whereby it acts as investment adviser to certain persons. Each person for whom Fuller & Thaler Asset Management, Inc. acts as investment adviser has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Common Stock purchased or held pursuant to such arrangements. Item 7. Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company. Not applicable. Item 8. Identification and Classification of Members of the Group. Not applicable. CUSIP No. 15115L103 SCHEDULE 13G Page 5 of 5 Item 9. Notice of Dissolution of Group. Not applicable. Item 10. Certification. By signing below, Fuller & Thaler Asset Management, Inc. certifies that, to the best of its knowledge and belief, the securities referred to above on page two (2) of this Schedule 13G were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Signature After reasonable inquiry and to the best of its knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct. DATED: August 3, 2004 Fuller & Thaler Asset Management, Inc. /s/ Martin M. Fawzy ________________________ By: S Martin M. Fawzy, CFIRS its: Director of Compliance -----END PRIVACY-ENHANCED MESSAGE-----